Top Markets
Coin of the day
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Classement en actions #33959
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Prix de l'action
$17.15
Dernière synchronisation: 2026-08-03
Capitalisation boursière
$6.51M
Changement (1 jour)
9.80%
Changement (1 an)
289.77%
Pays
US
Échange Galera Therapeutics, Inc. (GRTX)

Catégorie

Historique des divisions d’actions pour Galera Therapeutics, Inc. (GRTX)
L’action Galera Therapeutics, Inc. (symbole : GRTX) a subi un total de 1 divisions.
La division la plus récente a eu lieu le Jul 13, 2026.
Une action GRTX achetée avant le Jul 13, 2026 équivaudrait aujourd’hui à 0.005 actions GRTX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2026-07-13 1:200 x0.005 x0.005
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE